PRELUDE CAPITAL MANAGEMENT, LLC - ADVERUM BIOTECHNOLOGIES INC ownership

ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 58 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of ADVERUM BIOTECHNOLOGIES INC
ValueSharesWeighting
Q3 2020$76,000
+230.4%
7,400
+85.0%
0.00%
+100.0%
Q1 2018$23,000
+2200.0%
4,000
+900.0%
0.00%
Q2 2017$1,0000.0%4000.0%0.00%
Q1 2017$1,0004000.00%
Other shareholders
ADVERUM BIOTECHNOLOGIES INC shareholders Q3 2017
NameSharesValueWeighting ↓
Sonic Fund II, L.P. 4,112,355$85,866,00042.72%
Versant Venture Management, LLC 7,003,892$146,241,265,00021.01%
ACUTA CAPITAL PARTNERS, LLC 1,746,500$36,467,00010.54%
SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) 480,000$10,022,0005.33%
Ghost Tree Capital, LLC 900,000$18,792,0004.96%
RTW INVESTMENTS, LP 6,790,027$141,776,0003.99%
RA Capital Management 7,801,641$162,898,0003.17%
Avoro Capital Advisors LLC 7,585,000$158,375,0003.13%
FRAZIER MANAGEMENT LLC 1,437,028$30,005,0002.64%
Soleus Capital Management, L.P. 218,723$4,566,0002.60%
View complete list of ADVERUM BIOTECHNOLOGIES INC shareholders